(Q43152301)

14 November 2017

title

Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels (English)

1 reference

14 November 2017

E Teijeira-Fernandez

1

1 reference

14 November 2017

S Eiras

2

1 reference

14 November 2017

L Grigorian-Shamagian

3

1 reference

14 November 2017

A Salgado-Somoza

4

1 reference

14 November 2017

J M Martinez-Comendador

5

1 reference

14 November 2017

J R Gonzalez-Juanatey

6

1 reference

14 November 2017

language of work or name

English

0 references

publication date

23 February 2010

1 reference

International Journal of Obesity

14 November 2017

published in

1 reference

14 November 2017

volume

34

1 reference

14 November 2017

issue

7

1 reference

14 November 2017

page(s)

1200-1208

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.30

14 November 2017

exact match

0 references

cites work

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Human epicardial adipose tissue is a source of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Hyperleptinemia: protecting the heart from lipid overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Modulation of insulin activities by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Leptin enhances the calcification of vascular cells: artery wall as a target of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Human leptin stimulates proliferation and activation of human circulating monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Leptin and coronary heart disease: prospective study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Relationship of epicardial fat thickness and fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Increased adiponectin synthesis in the visceral adipose tissue in men with coronary artery disease treated with pravastatin: a role of the attenuation of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Effect of pravastatin on the development of diabetes and adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

Adiponectin and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

[Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery].

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology"

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.30

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.30

1 reference

14 November 2017

1 reference